JF
CDMO

Jump Financial’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Jump Financial’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-86,540
Closed -$985K – 2087
2024
Q3 		$985K Sell
86,540
-33,660
-28% -$338K 0.02% 801
2024
Q2 		$858K Sell
120,200
-59,775
-33% -$457K 0.02% 888
2024
Q1 		$1.21M Buy
179,975
+35,926
+25% +$247K 0.03% 689
2023
Q4 		$936K Buy
+144,049
New +$928K 0.03% 755
2022
Q4 		– Sell
-53,849
Closed -$1.03M – 2104
2022
Q3 		$1.03M Buy
+53,849
New +$981K 0.04% 610

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Jump Financial's CDMO Position: Q4 2024 in Review

Jump Financial sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 86,540 shares — an estimated $985K sold.

Jump Financial first reported a position in CDMO in Q3 2022 and held it in 5 quarters. The position peaked at $1.21M in Q1 2024. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

  • Jump Financial reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Jump Financial sold 86,540 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $985K.
  • Jump Financial first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
  • Jump Financial's Avid Bioservices, Inc. Common Stock position peaked at $1.21M in Q1 2024.
  • 195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on Jump Financial's 13F filing for Q4 2024, filed 13 Feb 2025.